Lexaria Bioscience LEXX Stock
Lexaria Bioscience Price Chart
Lexaria Bioscience LEXX Financial and Trading Overview
Lexaria Bioscience stock price | 1.53 USD |
Previous Close | 0.72 USD |
Open | 0.73 USD |
Bid | 0 USD x 3100 |
Ask | 0 USD x 1000 |
Day's Range | 0.65 - 0.73 USD |
52 Week Range | 0.65 - 3.6 USD |
Volume | 155.53K USD |
Avg. Volume | 141.53K USD |
Market Cap | 5.58M USD |
Beta (5Y Monthly) | 1.104225 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.5 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 14 USD |
LEXX Valuation Measures
Enterprise Value | 469.83K USD |
Trailing P/E | N/A |
Forward P/E | -0.82166666 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 16.078098 |
Price/Book (mrq) | 0.825598 |
Enterprise Value/Revenue | 1.353 |
Enterprise Value/EBITDA | -0.068 |
Trading Information
Lexaria Bioscience Stock Price History
Beta (5Y Monthly) | 1.104225 |
52-Week Change | -70.38% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3.6 USD |
52 Week Low | 0.65 USD |
50-Day Moving Average | 1.35 USD |
200-Day Moving Average | 2.33 USD |
LEXX Share Statistics
Avg. Volume (3 month) | 141.53K USD |
Avg. Daily Volume (10-Days) | 46.7K USD |
Shares Outstanding | 8.09M |
Float | 4.71M |
Short Ratio | 0.94 |
% Held by Insiders | 18.39% |
% Held by Institutions | 11.69% |
Shares Short | 342.95K |
Short % of Float | 4.59% |
Short % of Shares Outstanding | 4.24% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | August 31, 2022 |
Most Recent Quarter (mrq) | February 28, 2023 |
Next Fiscal Year End | August 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -2018.50% |
Gross Margin | 77.36% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -53.86% |
Return on Equity (ttm) | -88.46% |
Income Statement
Revenue (ttm) | 347.36K USD |
Revenue Per Share (ttm) | 0.06 USD |
Quarterly Revenue Growth (yoy) | 14.19% |
Gross Profit (ttm) | 183.56K USD |
EBITDA | -6913358 USD |
Net Income Avi to Common (ttm) | -6904466 USD |
Diluted EPS (ttm) | -1.13 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 3.54M USD |
Total Cash Per Share (mrq) | 0.59 USD |
Total Debt (mrq) | 29.08K USD |
Total Debt/Equity (mrq) | 0.63 USD |
Current Ratio (mrq) | 17.944 |
Book Value Per Share (mrq) | 0.836 |
Cash Flow Statement
Operating Cash Flow (ttm) | -4909335 USD |
Levered Free Cash Flow (ttm) | -1802199 USD |
Profile of Lexaria Bioscience
Country | United States |
State | BC |
City | Kelowna |
Address | 740 McCurdy Road |
ZIP | V1X 2P7 |
Phone | 250-765-6424 |
Website | https://lexariabioscience.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 7 |
Lexaria Bioscience Corp. operates as a biotechnology company. The company develops and out-licenses its DehydraTECH combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and various cannabinoids. The company's DehydraTECH technology evaluates for a variety of therapeutic indications, including hypertension, heart disease, dementia, and diabetes. It is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is based in Kelowna, Canada.
Q&A For Lexaria Bioscience Stock
What is a current LEXX stock price?
Lexaria Bioscience LEXX stock price today per share is 1.53 USD.
How to purchase Lexaria Bioscience stock?
You can buy LEXX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lexaria Bioscience?
The stock symbol or ticker of Lexaria Bioscience is LEXX.
Which industry does the Lexaria Bioscience company belong to?
The Lexaria Bioscience industry is Biotechnology.
How many shares does Lexaria Bioscience have in circulation?
The max supply of Lexaria Bioscience shares is 17.55M.
What is Lexaria Bioscience Price to Earnings Ratio (PE Ratio)?
Lexaria Bioscience PE Ratio is now.
What was Lexaria Bioscience earnings per share over the trailing 12 months (TTM)?
Lexaria Bioscience EPS is -0.5 USD over the trailing 12 months.
Which sector does the Lexaria Bioscience company belong to?
The Lexaria Bioscience sector is Healthcare.
Lexaria Bioscience LEXX included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}